ObsEva SA to Attend Jefferies Healthcare Conference in NYC

(Thomson Reuters ONE) -
ObsEva SA /
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.

Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a
Swiss biopharmaceutical company focused on the development and commercialization
of novel therapeutics for serious conditions that compromise a woman''s
reproductive health and pregnancy, today announced that Ernest LOUMAYE, M.D.,
Ph.D., CEO and Co-Founder, Tim ADAMS, CFO, and Mario CORSO, Senior Director
Investor Relations will attend the Jefferies Healthcare Conference. Management
will be presenting on Thursday June 8(th) at 08:30 a.m. and will be hosting one-
on-one meetings at the Grand Hyatt Hotel in New York City.


About ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical
development and commercialization of novel therapeutics for serious conditions
that compromise a woman''s reproductive health and pregnancy. Through strategic
in-licensing and disciplined drug development, ObsEva has established a late-
stage clinical pipeline with development programs focused on treating
endometriosis, uterine fibroids, preterm labor and improving ART outcomes.
ObsEva is listed on The NASDAQ Global Select Market and is trading under the
ticker symbol "OBSV". For more information, please visit www.ObsEva.com

###

Media Contact:
Liz Bryan
Spectrum Science
lbryan(at)spectrumscience.com
202-955-6222 x2526

Company Contact:
CEO Office contact
Delphine Renaud
delphine.renaud(at)obseva.ch
+41 22 552 1550

Investor Contact
Mario Corso
Senior Director, Investor Relations

mario.corso(at)obseva.com
781-366-5726



Press Release:
http://hugin.info/157613/R/2108510/800839.pdf



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: ObsEva SA via GlobeNewswire

More information:
http://muncheye.com http://www.realwire.com/releases/Tutela-hits-200-Million-Installs-with-1-billion-data-points-daily http://www.odfjell.com http://www.camposol.com.pe/ http://www.atosorigin.com/corporate/default.htm https://www.neste.com/en http://www.g

Keywords (optional):

Company information / Profile:

PressRelease by
ObsEva SA

Requests:

PressContact / Agency:

Date: 05/31/2017 - 13:00
Language: English
News-ID 1506764
Character count: 2440
Kontakt-Informationen:
Firma: ObsEva SA
Ansprechpartner:
Stadt: Plan-les-Ouates
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:

Number of hits: 114

Comments on this PressRelease